MID-REGIONAL PROADRENOMEDULLIN PREDICTS LONG-TERM MORTALITY IN PATIENTS WITH CHEST PAIN

Adrenomedullin (ADM) is a vasodilatory peptide that has not been evaluated in large populations of patients presenting with chest pain. The CHOPIN trial (Copeptin Helps in the early detection Of Patients with acute myocardial Infarction) was a 16-center trial which enrolled 2071 patients who